NIH-funded research R01 grant

Understanding how DNA changes contribute to colon cancer

Official title: Mechanisms of DNA methylation signaling and dysregulation in colon cancer

Funded at Van Andel Research Institute · NIH-10979595 · Data updated 2026-11-12

This study is looking at how changes in DNA can affect the development of colon cancer, with the goal of finding new ways to treat patients by understanding what goes wrong in their cells.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVan Andel Research Institute
NIH-funded
Lab location1 site (Grand Rapids, United States)
Project startJuly 2, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$632,319
NIH project number1R01CA283463-01A1
Project IDNIH-10979595 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with colon cancer or those at high risk for developing the disease due to genetic factors.

Less likely to help

Patients with non-colon cancers or those without any genetic predisposition to colon cancer may not benefit from this research.

What this research studies

This research investigates the role of DNA methylation, a process that can silence tumor suppressor genes, in the development of colon cancer. It aims to uncover the mechanisms behind abnormal DNA methylation patterns and how they lead to cancer progression. The study will explore the involvement of protein modifications in regulating DNA methylation and assess potential therapeutic targets to correct these abnormalities. By understanding these processes, the research hopes to provide insights into new treatment strategies for colon cancer patients.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that target the underlying mechanisms of colon cancer, potentially improving patient outcomes.

How similar studies have gone: Previous research has shown promising results in targeting DNA methylation and related pathways in cancer treatment, indicating that this approach has potential for success.

Where this research is happening

  • Van Andel Research Institute
    Grand Rapids, United States
    Active

Researchers

  • Principal investigator: Rothbart, Scott — Van Andel Research Institute
  • Study coordinator: Rothbart, Scott

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.